Albumin segment is expected to dominate the market due to its wide range of applications in treating various medical conditions such as burns, liver diseases, and hypoalbuminemia.
Factor VIII is anticipated to witness significant growth owing to the increasing prevalence of hemophilia A and the growing demand for factor VIII concentrates.
Factor IX segment is projected to grow steadily due to the rising prevalence of hemophilia B and the adoption of factor IX products for the treatment of the disease.
Immunoglobulin segment is expected to witness substantial growth due to the increasing prevalence of immunodeficiency diseases and the rising demand for immunoglobulin products for the treatment of these conditions.
Hyperimmune globulin segment is expected to grow at a rapid pace owing to its effectiveness in treating certain infectious diseases and its increasing adoption in clinical settings.
Others segment is projected to witness moderate growth due to the rising demand for other blood plasma derivatives for the treatment of various medical conditions.
Blood Plasma Derivatives Market By Application:
Haemophilia segment is expected to dominate the market due to the high prevalence of hemophilia and the growing demand for blood plasma derivatives for the treatment of the disease.
Hypogammaglobulinemia segment is anticipated to witness significant growth owing to the increasing prevalence of the condition and the rising demand for immunoglobulin products for its treatment.
Immunodeficiency diseases segment is projected to grow steadily due to the rising prevalence of various immunodeficiency diseases and the increasing adoption of blood plasma derivatives for their treatment.
Von Willebrand's Disease segment is expected to witness substantial growth due to the high prevalence of the disease and the growing demand for factor VIII concentrates for its treatment.
Other segment is expected to witness moderate growth due to the increasing adoption of blood plasma derivatives for the treatment of various other medical conditions.
Blood Plasma Derivatives Market By End-User:
Hospitals segment is expected to dominate the market due to the high patient footfall in hospitals and the increasing use of blood plasma derivatives for the treatment of various medical conditions.
Clinics segment is anticipated to witness significant growth owing to the rising number of clinics offering specialized treatment services and the increasing demand for blood plasma derivatives in clinical settings.
Other end users segment is projected to grow steadily due to the increasing adoption of blood plasma derivatives in non-traditional healthcare settings such as home healthcare and ambulatory care centers.